Lotensin HCT is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Validus Pharmaceuticals Llc. The primary component is Benazepril Hydrochloride; Hydrochlorothiazide.
Product ID | 30698-453_40bb04ea-bdb6-43d2-b734-6517157b9319 |
NDC | 30698-453 |
Product Type | Human Prescription Drug |
Proprietary Name | Lotensin HCT |
Generic Name | Benazepril Hydrochloride And Hydrochlorothiazide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1992-05-30 |
Marketing Category | NDA / NDA |
Application Number | NDA020033 |
Labeler Name | Validus Pharmaceuticals LLC |
Substance Name | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 20 mg/1; mg/1 |
Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1992-05-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020033 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1992-05-30 |
Ingredient | Strength |
---|---|
BENAZEPRIL HYDROCHLORIDE | 20 mg/1 |
SPL SET ID: | 94c4536f-e28e-48b1-8336-b3939917e99d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
30698-452 | Lotensin HCT | benazepril hydrochloride and hydrochlorothiazide |
30698-453 | Lotensin HCT | benazepril hydrochloride and hydrochlorothiazide |
30698-454 | Lotensin HCT | Lotensin HCT |
0185-0211 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0185-0236 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0185-0277 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0185-0325 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0378-4725 | Benazepril Hydrochloride and Hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0378-4735 | Benazepril Hydrochloride and Hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0378-4745 | Benazepril Hydrochloride and Hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0378-4775 | Benazepril Hydrochloride and Hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0574-0227 | benazepril hydrochloride and hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0574-0228 | benazepril hydrochloride and hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0574-0229 | benazepril hydrochloride and hydrochlorothiazide | benazepril hydrochloride and hydrochlorothiazide |
0832-0483 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0832-0484 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
0832-0485 | Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril Hydrochloride and Hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LOTENSIN HCT 74134117 1882770 Live/Registered |
NOVARTIS PHARMACEUTICALS CORPORATION 1991-01-28 |